Whole collection based on Evidence

SPRINT’s results upend hypertension targets

ORLANDO – Results from the SPRINT hypertension trial had been highly anticipated ever since the study stopped early in August and the sponsoring National Heart, Lung, and Blood Institute released the top-line positive result in September that treating systolic blood pressure to a target of less than 120 mm Hg led to statistically significant drops in a composite of cardiovascular endpoints as well as in all-cause death, compared with the standard target of less than 140 mm Hg. http://www.nejm.org/doi/full/10.1056/NEJMoa1511939?query=featured_home#t=articleTop